Highly fluorescent protein labeling using dendritic peptide derivatives

Journal of Peptide Research

Volumn 55, Issue 3, 2000, Pages 195-202

  Giovannoni, L ^b   Lozzi, L ^a   Neri, D ^c   Neri, Paolo ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Philogen SpA   (Italy)

^c ETH ZURICH   (Switzerland)

Author keywords

Calmodulin; Dendritic peptides; Fluorescent labeling; Recombinant antibodies

Indexed keywords

CALMODULIN; FLUORESCEIN; FLUORESCENT DYE; M PROTEIN; PEPTIDE DERIVATIVE; PHOTOSENSITIZING AGENT; RECOMBINANT ANTIBODY;

ARTICLE; BINDING AFFINITY; CONJUGATION; CONTROLLED STUDY; FLUORESCENCE; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN SYNTHESIS;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; CALMODULIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUORESCEIN; FLUORESCENT DYES; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PEPTIDES; PROTEIN BINDING; SPECTROMETRY, FLUORESCENCE;

EID: 0034000537     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3011.2000.00178.x     Document Type: Article

References (36)

1. 1. Gollnick, M.P. & Ianuzzo, C.D. (1968) Colonic temperature response of rats during exercise. J. Appl. Physiol. 6, 747-750.
2. 2. Weishaupt, K.R., Gomer, G.J. & Dougherty, T.J. (1976) Identification of single oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 36, 2326-2329.
3. 3. Levy, J.G. (1995) Photodynamic therapy. Trends Biotechnol. 13, 14-18.
4. 4. Ochsner, M. (1997) Photophysical and photobiological processes in the photodynamic therapy of tumors. J. Photochem. Photobiol. B 39, 1-18.
5. 5. Yarmush, M.L., Thorpe, W.P., Strong, L., Rakestraw, S.L., Toner, M. & Tompkins, R.G. (1993) Antibody targeted photolysis. Crit. Rev. Ther. Drug Carrier Syst. 10, 197-252.
6. 6. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1, 27-31.
7. 7. Folli, S., Westermann, P., Braichotte, D., Pelegrin, A., Weignieres, G., Van der Berg, H. & Mach, J.P. (1994) Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. Cancer Res. 54, 2643-2649.
8. 8. Goff, B.A., Blake, J., Bamberg, M.P. & Hassen, T. (1996) Treatment of ovarian cancer with photodinamic therapy and immunoconjugates in a murine ovarian cancer model. Br. J. Cancer 74, 1194-1198.
9. 9. Berkower, I. (1996) The promise and pitfalls of monoclonal antibody therapeutics. Curr Opin. Biotechnol. 7, 622-628.
10. 10. Bird, R.E., Hardman, K.D., Jacobson, J.W., Johnson, S., Kaufman, B.M., Lee, S.M., Lee, T., Pope, S.H., Riordan, G.S. & Whitlow, M. (1988) Single-chain antigen-binding proteins. Science 242, 423-426.
11. 11. Huston, J.S., Levinson, D., Mudgett, H.M., Tai, M.S., Novotny, J., Margolies, M.N., Ridge, R.J., Bruccoleri, R.E., Haber, E., Crea, R. & Oppermann, H. (1988) Protein engineering of antibody binding sites: recovery of specific activity in anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl Acad. Sci. USA 85, 5879-5883.
12. 12. Winter, G., Griffiths, A.D., Hawkins, R.E. & Hoogenboom, H.R. (1994) Making antibodies by phage display technology. Annu. Rev. Immunol. 12, 433-455.
13. 13. Vaughan, T.J., Williams, A.J., Pritchard, K., Osbourn, J.K., Pope, A.R., Earnshaw, J.C., McCafferty, J., Hodits, R.A., Wilton, J. & Johnson, K.S. (1996) Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nature Biotechnol. 14, 309-314.
14. 14. Pini, A., Viti, F., Santucci, A., Carnemolla, B., Zardi, L., Neri, P. & Neri, D. (1998) Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel. J. Biol. Chem. 273, 21769-21776.
15. 15. Pack, P., Kujau, M., Schroeckh, U., Knüpfer, R., Wenderoth, R., Riesenberg, D. & Plückthun, A. (1993) Improved bivalent miniantibodies, with identical avidity as whole antibodies, produced by high cell density fermentation of Escherichia coli. Bio/Technology 11, 1271-1277.
16. 16. Neri, D., Carnemolla, B., Nissim, A., Balza, E., Leprini, A., Querzë, G., Pini, A., Tarli, L., Halin, C., Neri, P., Zardi, L. & Winter, G. (1997) Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform. Nature Biotechnol. 15, 1271-1275.
17. 17. Zetter, B.R. (1997) On target with tumor blood vessel markers. Nature Biotechnol 15, 1243-1244.
18. 18. Schmidt-Erfurth, U., Miller, J., Sickenberg, M., Bunse, A., Laqua, H., Gragoudas, E., Zografos, L., Birngruber, R., van der Berg, H., Strong, A., Maujuris, U., Fsadni, M., Lane, A.M., Piguet, B. & Bressler, N.M. (1998) Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefes Arch. Clin. Exp. Ophthalmol. 5, 365-374.
19. 19. Cumber, A.J., Ward, E.S., Winter, G., Parnell, G.D. & Warzynczak, E.J. (1992) Comparative stabilities in vitro and in vivo of a recombinant mouse antibody FvCys fragment and a bisFvCys conjugate. J. Immunol, 149, 120-126.
20. 20. Neri, D., Momo, M., Prospero, T. & Winter, G. (1995) High-affinity antigen binding by chelating recombinant antibodies (CRAbs). J. Mol. Biol. 246, 367-373.
21. 21. Neri, D., Natali, P.G., Petrul, H., Soldani, P., Vola, R., Nicotra, M.R., Rivella, A., Creighton, A.M., Neri, P., Winter, G. & Mariani, M. (1996) Recombinant anti-human melanoma antibodies are versatile molecules. J. Invest. Dermatol. 107, 164-170.
22. 22. Neri, D., DeLalla, C, Neri, P. & Winter, G. (1995) Calmodulin as a versatile tag for antibody fragments. Bio/Technology 13, 373-377.
23. 23. Montigiani, S., Neri, G., Neri, P. & Neri, D. (1996) Alanine substitutions in calmodulin-binding peptides result in unexpected affinity enhancement. J. Mol. Biol. 258, 6-13.
24. 24. Koning, W. & Geiger, R. (1970) A new method for the synthesis of peptides: activation of the carboxy group with dicyclohexylcarbodiimide and 3-hydroxy-4-oxo-3,4-dihydro-1,2,3-benzotriazine. Chem. Ber. 103 (788), 2024-2034.
25. 1-3, J. Org. Chem. 57, 5399-5403.
26. 26. Giovannoni, L., Lozzi, L. & Neri, D. (1998) Pat. Appl. FI/98/A/121.
27. 35S] dithiobis (succinimidyl propionate). J. Mol. Biol. 104, 243-261.
28. 28. Hermanson, G.T. (1995). Bioconjugate Techniques, pp. 298-307, Academic Press, San Diego, CA.
29. 29. Neri, D., Prospero, T., Petrul, H., Winter, W., Browne, M. & Vanderpant, L. (1996) Multipurpose high sensitivity luminescence analyzer (LUANA): use in gel electrophoresis. Bio/Techniques 20, 708-713.
30. 30. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227, 680-685.
31. 31. Cox, J.A., Comte, M., Fitton, J.E. & DeGrado, W.F. (1985) The interaction of calmodulin with amphiphilic peptides. J. Biol Chem. 260, 2527-2534.
32. 32. Carnemolla, B., Neri, D., Castellani, P., Leprini, A., Neri, G., Pini, A., Winter, G. & Zardi, L. (1996) Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domain. Int. J. Cancer 68, 397-405.
33. 33. Macular Photocoagulation Study Group (1994) Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Arch. Ophtalmol. 112, 480-488.
34. 34. Haimovici, R., Kramer, M., Miller, J.W., Hasan, T., Flotte, T.J., Schomacker, K.T. & Gragoudas, E.S. (1997) Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye. Curr. Eye Res. 16, 83-90.
35. 35. Schmidt-Erfurth, U., Miller, J., Sickenberg, M., Bunse, A., Laqua, H., Gradoudas, E., Zografos, L., Birngruber, R., van den Bergh, H., Strong, A., Manjuris, U., Fsadni, M., Lane, A.M., Piguet, B. & Bressler, N.M. (1988) Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefes Arch. Clin. Exp. Ophthalmol. 236, 365-374.
36. 36. Birchler, M., Viti, F., Zardi, L., Spiess, B. & Neri, D. (1999) Selective targeting and photocoagulation of ocular angiogenesis mediated by phage-derivated human antibody fragments. Nat Biotechnol. 17, 984-988.